Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · OOB

Drug-Eluting Percutaneous Transluminal Coronary Angioplasty Catheter

A drug-eluting percutaneous transluminal coronary angioplasty catheter is a combination product intended for balloon dilatation of a hemodynamically significant coronary artery or bypass graft stenosis in patients evidencing coronary ischemia for the purpose of improving myocardial perfusion. A drug-eluting ptca catheter may also be intended for the treatment of acute myocardial infarction; Treatment of in-stent restenosis (isr) and/or post-deployment stent expansion. A drug-eluting ptca catheter delivers a drug to the vessel as part of the angioplasty procedure, which is intended to inhibit restenosis.

Product / regulatory recordCompanyPathwayDecision dateSource
MedAlliance, LLCPMA supplementNov 6, 2026FDA
MedAlliance, LLCPMA approvalSep 18, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementAug 28, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementJul 30, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementFeb 11, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementOct 24, 2025FDA
Source information

Follow the FDA links to view the original records.

All device categories